Literature DB >> 27179125

Mild Reinforcement Learning Deficits in Patients With First-Episode Psychosis.

Wing Chung Chang1,2, James A Waltz3, James M Gold3, Tracey Chi Wan Chan1, Eric Yu Hai Chen1,2.   

Abstract

Numerous studies have identified reinforcement learning (RL) deficits in schizophrenia. Most have focused on chronic patients with longstanding antipsychotic treatment, however, and studies of RL in early-illness patients have produced mixed results, particularly regarding gradual/procedural learning. No study has directly contrasted both rapid and gradual RL in first-episode psychosis (FEP) samples. We examined probabilistic RL in 34 FEP patients and 36 controls, using Go/NoGo (GNG) and Gain vs Loss-Avoidance (GLA) paradigms. Our results were mixed, with FEP patients exhibiting greater impairment in the ability to use positive, as opposed to negative, feedback to drive rapid RL on the GLA, but not the GNG. By contrast, patients and controls showed similar improvement across the acquisition. Finally, we found no significant between-group differences in the postacquisition expression of value-based preference in both tasks. Negative symptoms were modestly associated with RL measures, while the overall bias to engage in Go-responding correlated significantly with psychosis severity in FEP patients, consistent with striatal hyperdopaminergia. Taken together, FEP patients demonstrated more circumscribed RL impairments than previous studies have documented in chronic samples, possibly reflecting differential symptom profiles between first-episode and chronic samples. Our finding of relatively preserved gradual/procedural RL, in briefly medicated FEP patients, might suggest spared or restored basal ganglia function. Our findings of preserved abilities to use representations of expected value to guide decision making, and our mixed results regarding rapid RL, may reflect a lesser degree of prefrontal cortical functional impairment in FEP than in chronic samples. Further longitudinal research, in larger samples, is required.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  basal ganglia; decision making; dopamine; prediction error; prefrontal cortex; psychosis

Mesh:

Substances:

Year:  2016        PMID: 27179125      PMCID: PMC5049533          DOI: 10.1093/schbul/sbw060

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  57 in total

1.  Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging.

Authors:  O Monchi; M Petrides; V Petre; K Worsley; A Dagher
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

2.  Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input.

Authors:  Thomas W Weickert; Alejandro Terrazas; Llewellyn B Bigelow; James D Malley; Thomas Hyde; Michael F Egan; Daniel R Weinberger; Terry E Goldberg
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

3.  Patients with schizophrenia are impaired when learning in the context of pursuing rewards.

Authors:  Jenna Reinen; Edward E Smith; Catherine Insel; Robert Kribs; Daphna Shohamy; Tor D Wager; L Fredrik Jarskog
Journal:  Schizophr Res       Date:  2013-12-13       Impact factor: 4.939

4.  Learning to avoid in older age.

Authors:  Michael J Frank; Lauren Kong
Journal:  Psychol Aging       Date:  2008-06

Review 5.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

6.  Expected value and prediction error abnormalities in depression and schizophrenia.

Authors:  Victoria B Gradin; Poornima Kumar; Gordon Waiter; Trevor Ahearn; Catriona Stickle; Marteen Milders; Ian Reid; Jeremy Hall; J Douglas Steele
Journal:  Brain       Date:  2011-04-10       Impact factor: 13.501

7.  A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

Authors:  Michael J Frank; Randall C O'Reilly
Journal:  Behav Neurosci       Date:  2006-06       Impact factor: 1.912

8.  Abnormal negative feedback processing in first episode schizophrenia: evidence from an oculomotor rule switching task.

Authors:  V C Huddy; T L Hodgson; M A Ron; T R E Barnes; E M Joyce
Journal:  Psychol Med       Date:  2011-01-07       Impact factor: 7.723

9.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

10.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

View more
  12 in total

1.  Deficits in reinforcement learning but no link to apathy in patients with schizophrenia.

Authors:  Matthias N Hartmann-Riemer; Steffen Aschenbrenner; Magdalena Bossert; Celina Westermann; Erich Seifritz; Philippe N Tobler; Matthias Weisbrod; Stefan Kaiser
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

2.  Social motivation in people with recent-onset schizophrenia spectrum disorders.

Authors:  Timothy R Campellone; Brandy Truong; David Gard; Danielle A Schlosser
Journal:  J Psychiatr Res       Date:  2018-01-12       Impact factor: 4.791

Review 3.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  Impaired Expected Value Computations Coupled With Overreliance on Stimulus-Response Learning in Schizophrenia.

Authors:  Dennis Hernaus; James M Gold; James A Waltz; Michael J Frank
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-04-03

5.  Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia.

Authors:  Lucy D Vanes; Elias Mouchlianitis; Tracy Collier; Bruno B Averbeck; Sukhi S Shergill
Journal:  Psychol Med       Date:  2018-02-14       Impact factor: 10.592

6.  Reinforcement learning as an intermediate phenotype in psychosis? Deficits sensitive to illness stage but not associated with polygenic risk of schizophrenia in the general population.

Authors:  Marcella Montagnese; Franziska Knolle; Joost Haarsma; Juliet D Griffin; Alex Richards; Petra E Vertes; Beatrix Kiddle; Paul C Fletcher; Peter B Jones; Michael J Owen; Peter Fonagy; Edward T Bullmore; Raymond J Dolan; Michael Moutoussis; Ian M Goodyer; Graham K Murray
Journal:  Schizophr Res       Date:  2020-05-07       Impact factor: 4.939

7.  Decision making under ambiguity and risk in adolescent-onset schizophrenia.

Authors:  Dandan Li; Fengyan Zhang; Lu Wang; Yifan Zhang; Tingting Yang; Kai Wang; Chunyan Zhu
Journal:  BMC Psychiatry       Date:  2021-05-04       Impact factor: 3.630

8.  Reduced learning bias towards the reward context in medication-naive first-episode schizophrenia patients.

Authors:  Xiaoyan Cheng; Lingling Wang; Qinyu Lv; Haisu Wu; Xinxin Huang; Jie Yuan; Xirong Sun; Xudong Zhao; Chao Yan; Zhenghui Yi
Journal:  BMC Psychiatry       Date:  2022-02-16       Impact factor: 3.630

9.  Altered risky decision making in patients with early non-affective psychosis.

Authors:  Luk Msk; Chang Wc; Chong Csy; Siu Cmw; Chan Skw; Lee Emh; Hui Clm; Sun Yn; Lee Tmc; Lo Tl; Chen Eyh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-02-26       Impact factor: 5.270

10.  Both unmedicated and medicated individuals with schizophrenia show impairments across a wide array of cognitive and reinforcement learning tasks.

Authors:  Erin K Moran; James M Gold; Cameron S Carter; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Steven J Luck; Deanna M Barch
Journal:  Psychol Med       Date:  2020-08-17       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.